Argeris N Karabelas Regenxbio Inc. (RGNX) insider trading activity

Argeris N Karabelas is of REGENXBIO Inc.. Currently has a direct ownership of 11,286 shares of RGNX, which is worth approximately $99,203. The most recent transaction as insider was on Oct 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $10.11 per share, resulting in proceeds of $101,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3K

0% 3M change

73.74% 12M change

Total Value Held $99,203

ARGERIS N KARABELAS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2024	SELL Open market or private sale	$101,100 $10.11 p/Share	10,000 Reduced 46.98%	11,286 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$37,600 $3.76 p/Share	10,000 Added 31.96%	21,286 Common Stock
Sep 03 2024	SELL Open market or private sale	$119,200 $11.92 p/Share	10,000 Reduced 46.98%	11,286 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$37,600 $3.76 p/Share	10,000 Added 31.96%	21,286 Common Stock
Aug 01 2024	SELL Open market or private sale	$144,935 $14.35 p/Share	10,100 Reduced 47.23%	11,286 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$83,325 $8.25 p/Share	10,100 Added 32.08%	21,386 Common Stock
Jul 29 2024	SELL Open market or private sale	$165,440 $15.04 p/Share	11,000 Reduced 49.36%	11,286 Common Stock
Jul 29 2024	BUY Exercise of conversion of derivative security	$140,140 $12.74 p/Share	11,000 Added 33.05%	22,286 Common Stock
Jul 01 2024	SELL Open market or private sale	$112,700 $11.27 p/Share	10,000 Reduced 46.98%	11,286 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$37,600 $3.76 p/Share	10,000 Added 31.96%	21,286 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	4,790 Added 29.8%	11,286 Common Stock
Jun 02 2023	BUY Grant, award, or other acquisition	-	3,486 Added 34.92%	6,496 Common Stock
Jun 03 2022	BUY Grant, award, or other acquisition	-	3,010 Added 50.0%	3,010 Common Stock

Also insider at

BHC

Bausch Health Companies Inc. Healthcare

Director

ANK